Evaluation of the cervical liquid-based cytology sample as a microbiome resource for dual diagnosis

PLoS One. 2024 Dec 11;19(12):e0308985. doi: 10.1371/journal.pone.0308985. eCollection 2024.

Abstract

Cervical cancer, which is mainly caused by oncogenic human papillomavirus subtypes, remains a significant global health challenge. Recent studies have indicated a connection between cervical cancer and the uterine microbiome, underscoring its importance. This study explored the potential of liquid-based cytology (LBC) samples, which are typically used for cytological analysis, in investigating the cervical microbiome. Thirty women participated in the study and provided clinical information. Three samples were obtained from each participant: one for clinical purposes using LBC, another for microbiome sampling using LBC, and a third using the SWAB Microbiome kit. The LBC and traditional swab (SWAB) samples were subjected to high-throughput 16S rRNA gene sequencing for microbiome analysis. The results revealed a consistent dominance of key taxa, particularly Lactobacillus spp. The analysis of differential abundance highlighted variations in microbial abundance among individuals, which were more prominent than those resulting from the sampling methods. Functional analysis identified arachidonic acid and alpha-linolenic acid metabolism, along with a cautionary note regarding the low mean proportion values. The network analysis revealed positive correlations between indicators of structure among the networks, highlighting the robustness of microbiome similarities despite the diversity of sampling methods. Supervised machine learning has revealed challenges in distinguishing LBC and SWAB samples based on their microbiome features. Weighted co-expression network analysis revealed that the correlation between microbial clusters and the sampling method with clinical data was not significant. This study emphasizes the similarity in microbial communities observed using the LBC and SWAB methods, highlighting the potential of using dual diagnostic approaches. Additionally, the use of residual LBC samples in large-scale microbiological studies can provide comprehensive insights into cervical health and disease.

MeSH terms

  • Adult
  • Cervix Uteri* / microbiology
  • Cervix Uteri* / pathology
  • Cytodiagnosis / methods
  • Female
  • Humans
  • Microbiota* / genetics
  • Middle Aged
  • RNA, Ribosomal, 16S* / genetics
  • Uterine Cervical Neoplasms* / diagnosis
  • Uterine Cervical Neoplasms* / microbiology
  • Vaginal Smears / methods

Substances

  • RNA, Ribosomal, 16S

Grants and funding

Ildong Bioscience provided the samples for this research, and sequencing was conducted by HEM Pharma. This research was supported by the Chung-Ang University Graduate Research Scholarship (Academic Scholarship for the College of Biotechnology and Natural Resources) in 2023, awarded to J.Y. Lee. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.